- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Events
Page 316
Lim links up with SGInnovate
Former NTUitive chief executive Jui Lim will lead the Singaporean government's deep tech-focused investment unit from this May.
Mar 26, 2020Daily deal net: March 25, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Mar 25, 2020CVC in the Time of Coronavirus: Donald Lacey, Ping An Global Voyager…
The Ping An subsidiary is providing strategic assistance to portfolio companies during the Covid-19 pandemic, though managing director Lacey cautioned that startups with high burn rates are facing high risk.
Mar 25, 2020Frontier IP banks $2.8m profit
Frontier IP's half-year profit rose 86% in dollars to the end of 2019 but its stocks are now under pressure in the current economic climate.
Mar 25, 2020Abbisko absorbs $70m
Lilly Asia Ventures, an investor in the cancer drug developer since its series A round, returned to back a series C that doubled its overall funding to $140m.
Mar 25, 2020Dragonfly Therapeutics drags financing to $300m
Dragonfly, whose co-founders include MIT and UC Berkeley faculty, has boosted its total financing to $300m in round of undisclosed size led by Fidelity.
Mar 25, 2020Daily deal net: March 24, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Mar 24, 2020CureFit cuts to $109m round
Unilever Ventures returned to back a round led by Temasek that expanded the health and wellness services platform's overall financing to approximately $390m.
Mar 24, 2020Dragonfly Therapeutics drags financing to $300m
Celgene-backed immuno-oncology drug developer Dragonfly Therapeutics boosted its total financing to $300m in round of undisclosed size led by Fidelity.
Mar 24, 2020Design unlocks $45m series A
University of Wisconsin-Madison gene medicine developer Design Therapeutics has attracted SR One for its series A round.
Mar 23, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


